chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Past the 30 day beyond use date; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Past the 30 day beyond use date) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 037A21B) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced EXPIRED PRODUCT ADMINISTERED (Past the 30 day beyond use date). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Past the 30 day beyond use date) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   The vials did not undergone previous temperature excursion.  The vials were removed from the freezer on 03-Sep-2021 and  17-Sep-2021. Date of administration (if applicable) 03-Sept-2021 and 17-Sept-2021.  No concomitant medications were provided. No treatment information was reported.
Nausea the following day (12/22)--@ 11AM. Vaccination at 550PM the night before 12/21. no medications needed. mild arm soreness at injection site on 12/22. All have since resolved.
Patients have been administered doses while the temperature excursion assessment was ongoing (possible temperature excursion); Patients have been administered doses while the temperature excursion assessment was ongoing (possible temperature excursion); This spontaneous case was reported by an other health care professional and describes the occurrence of PRODUCT TEMPERATURE EXCURSION ISSUE (Patients have been administered doses while the temperature excursion assessment was ongoing (possible temperature excursion)) and POOR QUALITY PRODUCT ADMINISTERED (Patients have been administered doses while the temperature excursion assessment was ongoing (possible temperature excursion)) in a 48-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) .25 milliliter. On an unknown date, the patient experienced PRODUCT TEMPERATURE EXCURSION ISSUE (Patients have been administered doses while the temperature excursion assessment was ongoing (possible temperature excursion)) and POOR QUALITY PRODUCT ADMINISTERED (Patients have been administered doses while the temperature excursion assessment was ongoing (possible temperature excursion)). At the time of the report, PRODUCT TEMPERATURE EXCURSION ISSUE (Patients have been administered doses while the temperature excursion assessment was ongoing (possible temperature excursion)) and POOR QUALITY PRODUCT ADMINISTERED (Patients have been administered doses while the temperature excursion assessment was ongoing (possible temperature excursion)) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No Concomitant product use was reported.  It was reported that there had been no power outages that would have impacted the Moderna vaccine. However, the reporter reiterated that because their facility was unable to download the digital data logger, they would need to treat the issue as a temperature excursion. The data logger that caller was unable to download were for the months of Dec-2021, Jan-2022, and Feb-2022. It was also reported that no adverse reactions were reported by patient.  No treatment information was provided.   This case was linked to MOD-2022-501575 (Patient Link).
flu like symptoms; lots of coughing; chills; This spontaneous case was reported by a consumer and describes the occurrence of INFLUENZA LIKE ILLNESS (flu like symptoms), COUGH (lots of coughing) and CHILLS (chills) in a 68-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 015M20A) for COVID-19 vaccination.     No medical history reported.    On 12-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 12-Feb-2021, the patient experienced INFLUENZA LIKE ILLNESS (flu like symptoms), COUGH (lots of coughing) and CHILLS (chills). At the time of the report, INFLUENZA LIKE ILLNESS (flu like symptoms), COUGH (lots of coughing) and CHILLS (chills) outcome was unknown.      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   No relevant concomitant medications were reported.  No treatment information was provided.
30 mins after the shot on my left upper arm my left hand was tingling then I had a bitter taste in my mouth then numbness and tingling on the back of my tongue on the left side, felt high,
Injection site became red with a 3" circle of redness.  Injection site was extremely tender within an hour of receiving it.  About 3 hours after injection body aches began.  About 5 hours after injection, felt feverish but had not fever, body aches intensified, felt nauseous, and injection site so tender couldn't touch it.    19 hours after injection, took 2 Advil and they made me feel better.  Still felt ill, but not as severe.  28 hours after injection, all symptoms returned and more severe.  Felt as is I was sick with a virus ( body aches, joint aches, felt hot at times, but no fever, nauseous, headache, exhausted)  42 hours after injection still felt sick, but not as severe (headache, body aches, joint aches, tired, hot but no fever).  By 54 hours after injection I was less tired and less body aches.  Redness around injection site still there, but less tender.
Patient stated that she has had an adverse reaction to a flu shot previously where she briefly fainted. However, patient stated that she has a fear of needles that contributes to the fainting and hyperventilating. However, she has had other vaccines administered since the flu fainting incident without any issues. She wanted to proceed with the covid vaccine.  About 10 minutes after receiving the vaccine, the patient didn't look completely well. I went out to assist and patient said she felt weak/faint and broke out in a sweat.  I held patient to ensure she didn't fall out of chair.  assisted by bringing an ice pack, cool cloth, fan, and bottle of water. After cooling off, the patient stated she was feeling better and was encouraged to continue to sit a while longer. Finally, the patient said she felt normal and went on her way.
The patient called saying that she noticed today her arm is swollen, hot, hurts, and is red.
2/2 10:30pm - extremely cold. hands and feet were like ice. 7 blankets to get warm. 3mg of melatonin. 2/3 2:30am - became hot and achy. hard to sleep. took another 3mg of melatonin. fell back to sleep a little after 4am 2/3 9:15am - woke. achy all day. continued to be hot and cold. extreme fatigue. slept much of the day.  2/3 8pm - headache began. took 40mg of Relpax and 6mg of melatonin. no other medication was taken 2/4 - felt much better.
pt recvd vax 12OCT92 no problems until 14OCT92 started running fever; would go up & down took to hosp on 16OCT92 & was adm w/high fever; fever went to 106-107; had meningitis; viral illness, pos beta strep on antigen panel of CSF; WBC 27;
Pfizer booster vaccine; Extreme hair loss/lost like 75% of her hair; This is a spontaneous report from a Contactable consumer (Patient) via Pfizer sales representative.  A female patient of an unspecified age received booster dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, lot number and expiration date were not reported) via an unspecified route of administration on an unspecified date as dose 3 (booster), single for covid-19 immunization. The patient's medical history and concomitant medications were not reported. Historical vaccine included first and second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, lot number and expiration date were not reported), via an unspecified route of administration on an unspecified date as dose 1, single and dose 2, single for COVID-19 immunization. On an unspecified date, patient experienced pfizer booster vaccine, extreme hair loss/lost like 75% of her hair. The outcome of events was unknown.  The lot number for the vaccine, [BNT162B2], was not provided and will be requested during follow up.
epilepsy; RSV; received PROQUAD on 11/18/2021 at 1 year old and then received a 2nd dose of PROQUAD on 3/9/2022.; This spontaneous report has been received from a consumer referring to a 1-year-old female patient. Information of concurrent condition, pertinent medical history and concomitant medication was not reported. No known drug allergies (NKDA).   On 18-NOV-2021, the patient received measles, mumps, rubella and varicella (oka-merck) virus vaccine live (PROQUAD) subcutaneous injection for prophylaxis. And then, on 09-MAR-2022, the patient received a 2nd dose of measles, mumps, rubella and varicella (oka-merck) virus vaccine live (PROQUAD) subcutaneous injection for prophylaxis (both strength, dose, frequency, lot#, expiration date, route of administration and anatomical location were unknown).  In April 2022 (conflicting information: also reported as 09-MAR-2022), the patient started having seizures and had been diagnosed with epilepsy. In 2022, the patient experienced Respiratory syncytial virus infection (RSV). The patient was hospitalized in October 2022 for seizures and RSV. The patient had sought medical attention. Electroencephalography (EEG) and magnetic resonance imaging (MRI) were ordered. The outcome of the events was reported as not recovered.   The causality assessment between the suspect product and events was not provided.  Upon internal review, the event epilepsy was determined to be medically significant.
outbreak of mosquito type bumps yesterday which became vesicular overnite.  A febrile.  Comfort measures for treatment.
This spontaneous prospective pregnancy report as received from a female patient who currently at the time of the report was 17 year old with amoxicillin allergy, reporting on herself. In 2013 (exact date was not reported) the patient received a second dose of VARIVAX (Merck) injection (lot number, dose, route and site of administration were not reported). The patient was 18 weeks pregnant, when she received a vaccine. Last menstrual period was calculated as 06-MAY-2013 and EDD (estimate delivery date) would be on 10-FEB-2014. The pregnancy outcome was pending. The patient did not seek medical attention. None lab diagnostics were performed. Additional information has been requested.
This spontaneous case was reported by a consumer and describes the occurrence of IMMUNISATION REACTION (Rushed to the hospital after Moderna Vaccine) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 prophylaxis. No Medical History information was reported. On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced IMMUNISATION REACTION (Rushed to the hospital after Moderna Vaccine) (seriousness criterion hospitalization prolonged). At the time of the report, IMMUNISATION REACTION (Rushed to the hospital after Moderna Vaccine) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown. No concomitant medication was reported. No treatment information was provided. This case was identified as part of a retrospective clean-up activity where certain emails received in the Moderna mailbox were missed to be booked-in. Company comment: This spontaneous case concerns a male patient of unspecified age with no medical history reported, who experienced the unexpected serious (Hospitalization) event of Immunisation reaction that occurred in the context of a dose (reported as 1 dosage) of mRNA-1273 vaccination. Latency cannot be assessed since vaccination date was not disclosed. Patient was rushed to the hospital after Moderna Vaccine. No further information on risk factors, clinical course, investigations and treatment received was available in the report. Outcome of the event was not known at the time of report. The benefit-risk relationship of mRNA-1273 Vaccine is not affected by this report. Event seriousness assessed as per medical judgement. Most recent FOLLOW-UP information incorporated above includes: On 27-Aug-2021: Follow-up received contains no new information (NNI). Sender's Comments: This spontaneous case concerns a male patient of unspecified age with no medical history reported, who experienced the unexpected serious (Hospitalization) event of Immunisation reaction that occurred in the context of a dose (reported as 1 dosage) of mRNA-1273 vaccination. Latency cannot be assessed since vaccination date was not disclosed. Patient was rushed to the hospital after Moderna Vaccine. No further information on risk factors, clinical course, investigations and treatment received was available in the report. Outcome of the event was not known at the time of report. The benefit-risk relationship of mRNA-1273 Vaccine is not affected by this report. Event seriousness assessed as per medical judgement.
0.3ml of dose given initially and error discovered in need for additional 0.2ml and 0.2ml dose Moderna same  lot administered
Arm was burning down to elbow. Hour after shot, bad headache. Headache lasted for 10 days, Nausea for a week, Joints were throbbing.
rash around the injection site; Tired; This spontaneous case was reported by a consumer and describes the occurrence of FATIGUE (Tired) and VACCINATION SITE RASH (rash around the injection site) in a 58-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 011M20A) for COVID-19 vaccination.     No medical history was given.  Concomitant products included ESCITALOPRAM, ARIPIPRAZOLE and ACETYLSALICYLIC ACID (BABY ASPIRIN) for an unknown indication.    On 04-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 04-Feb-2021, the patient experienced FATIGUE (Tired). On 18-Feb-2021, the patient experienced VACCINATION SITE RASH (rash around the injection site). The patient was treated with PARACETAMOL (TYLENOL) at a dose of 500 milligram. At the time of the report, FATIGUE (Tired) and VACCINATION SITE RASH (rash around the injection site) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant medications include Anti-depressants (Names were not specified).   This case was linked to MOD-2021-036334 (Patient Link).   Most recent FOLLOW-UP information incorporated above includes: On 05-Aug-2021: Follow-up received on 5-Aug-2021 contains significant information. Additional  event Rash around vaccination site, Concomitant medications- Anti-depressants was added On 05-Aug-2021: Non Significant follow up
fever; chills; headache; overall fatigue; pain and tenderness at injection site as well as in the armpit underneath the injection site; pain and tenderness at injection site as well as in the armpit underneath the injection site; patient with autoimmune thyroiditis (not yet clear if Hashimoto's or Graves) received PfizerBiontech Covid-19 Vaccine; patient with autoimmune thyroiditis (not yet clear if Hashimoto's or Graves) received PfizerBiontech Covid-19 Vaccine; This is a spontaneous report from a contactable healthcare professional (patient). A 26-year-old non-pregnant female patient received her second dose of bnt162b2 (BNT162B2 reported as PFIZERBIONTECH COVID-19 VACCINE; unknown lot number and expiration date) at vaccination age of 26-year-old intramuscularly in the left arm on 26Jan2021 12:15 at a single dose for covid-19 immunization. Medical history included autoimmune thyroiditis (not yet clear if Hashimoto's or Graves), appendicectomy and pyelonephritis. The patient was not diagnosed with Covid-19 prior to vaccination. Concomitant medication included methimazole, atenolol, valaciclovir hydrochloride (VALACYCLOVIR HCL), ethinylestradiol, norgestimate (NORGESTIMATE & ETHINYL ESTRADIOL) and magnesium. The patient did not receive other vaccine in four weeks. The patient previously took azithromycin but drug allergy. The patient received the first dose of of bnt162b2 (BNT162B2 reported as PFIZERBIONTECH COVID-19 VACCINE; unknown lot number and expiration date) at vaccination age of 26-year-old intramuscularly in the left arm on 05Jan2021 02:15 PM at a single dose for covid-19 immunization but had pain and tenderness at the injection site. It was reported that the patient with autoimmune thyroiditis (not yet clear if Hashimoto's or Graves) received PfizerBiontech Covid-19 Vaccine in a hospital on 26Jan2021 12:15. On 27Jan2021 12:00 AM, the patient had fever, chills, headache, overall fatigue, pain and tenderness at injection site as well as in the armpit underneath the injection site. The events required treatment which included acetaminophen. The outcome of the events was recovering.  Information on the lot/batch number has been requested.
I began having digestive issues in June 2021. Passing stool 10+ times a day, sometimes more. Occasionally severe abdominal pain, went to ER for severe pain in September. Began taking Prilosec OTC in October and it successfully controlled my symptoms.  Got a colonoscopy and endoscopy at the beginning of March. Results showed only minor gastritis. Told to continue taking Prilosec. If I stop taking it, the symptoms come back.
I had tingling in left arm and tips of fingers. I feel like I have been congestion and had a sore throat. I was prescribed Omeprazole in January as well as Celebrex for muscular aches and pain. They temporarily relieved my symptoms but when I stopped, they returned. I was prescribed Famotidine to treat the acid reflux and my sore throat. The medication improved the symptoms somewhat but not totally.  There were findings in the blood work, but I do not want to get into all that.  I went to the emergency room on November 30, 2022 for numbness on the side of my face.
I had a heart attacked 2/21/2023. I felt like a had food stuck in my throat or mucus about 2/4/2023. I was not not hungry and had loss of appetite. Five days later I sent to see the doctor on 2/6/2023 and was prescribed omeprazole. It helped by that evening the symptoms decreased and disappeared. The next week, I got these symptoms back. On 2/20/2023 it was more intense near my collarbone was sore. I could not exercise. Saw the doctor the next day and got an EKG and Blood drawn and was told to go the emergency room. I was rushed to a hospital. Cardiac catherization and found a blocked cartilage artery on the left there was blockage. A cat scan in Jan 2023 had zero blockage. They endoplasmic and put in a stent.
crying began 5hr p/vax given;hypertonic reflex began 30APR97 sending to ped neurologist for tx;
Daughter received first GARDASIL shot in June 2008. She passed out and hit her head getting a concussion -the Dr believed-. She had to stay in bed for over a week. She had severe headaches and neck pain. After the second shot, in September she also went to bed for about a week and a half. She had achiness all over especially in legs and stomach. The doctor ran CBC and xrays but could only find a slightly elevated protein level in the urine at this time. Because of these, she did not receive third vaccine. Over the winter, her toes started turning blue. She is now being tested for lupus. I will know the results in about one week, but if she has it I am sure it is from GARDASIL. This is a very dangerous vaccine and I wish I would have researched it more before forcing my daughter to receive it. I will never forgive myself for making her take this vaccine against her will. I was trying to help her by giving her a guaranteed cancer free future but may have ended up shortening her life or making her have a chronically ill life and she is only 17. I am so furious with the makers of this drug. If she tests positive for lupus, I plan on hiring a lawyer.
Sore arm; This non-serious case was reported by a consumer via interactive digital media and described the occurrence of pain in arm in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   On 16-MAR-2023, the patient received the 2nd dose of Shingles vaccine. On 16-MAR-2023, less than a day after receiving Shingles vaccine, the patient experienced pain in arm (Verbatim: Sore arm). The outcome of the pain in arm was not reported.   It was unknown if the reporter considered the pain in arm to be related to Shingles vaccine.     It was unknown if the company considered the pain in arm to be related to Shingles vaccine.   Additional Information: GSK Receipt Date: 16-MAR-2023 This case was reported by the patient via interactive digital media. The patient received his/her second shot of Shingles vaccine today (on day of reporting) and experienced sore arm, but he/she had that with any shot.  Follow-up would not possible, as no contact details were available.
Patient was in pharmacy 10/9/12 and reported her left arm was swollen and painful the evening she was administered PNEUMOVAX for which she sought medical treatment. Patient reported on 10/9/12 she had made full recovery.
This spontaneous case reported by a consumer, describes the occurrence of illness (sick in bed), dizziness, lethargy (lethargic), headache and nausea in a male patient, of an unknown age, who received mRNA-1273 (Moderna COVID-19 vaccine) for COVID-19 immunization. The occurrence of additional events detailed below. No medical history reported. On Jun 11, 2021, patient received the second dose of mRNA-1273 (Moderna COVID-19 vaccine), intramuscular; 1 dosage form. On an unknown date, patient received the first dose of mRNA-1273 (Moderna COVID-19 vaccine), unknown route; 1 dosage form. On Jun 12, 2021, patient experienced  lethargy (lethargic) and fatigue (tired). On Jun 14, 2021, patient had a headache, nausea and chills. On Jun 15, 2021, patient experienced illness (sick in bed). On an unknown date, patient experienced dizziness. On Jun 13, 2021, lethargy (lethargic) and fatigue (tired) resolved. At the time of the report, illness (sick in bed): not resolved; and dizziness, headache, nausea and chills outcome: unknown. No concomitant medication or treatment information reported. Most recent follow-up information incorporated: On Jun 15, 2021: Follow-up received on Jun 15, 2021 contained significant information: Product details including dose details and route of administration were updated. The new events added included lethargy, chills and illness.